ライフサイエンスコーパス: bioluminescence

1 ng "fire-body", derives from their brilliant bioluminescence.

2 to entrain the circadian rhythm in PER2::LUC bioluminescence.

3 reverse engineer promoter activity from the bioluminescence.

4 ve microbial behavior, such as virulence and bioluminescence.

5 onding mutants of NanoLuc that enable bright bioluminescence.

6 he spectrum of both downwelling sunlight and bioluminescence.

7 ng the possible role of ferritin in the worm bioluminescence.

8 phase when using a caliper as compared with bioluminescence.

9 nes to coordinate group behaviors, including bioluminescence.

10 ic slice cultures was monitored as PER2::LUC bioluminescence.

11 ently available luciferases that exhibit NIR bioluminescence.

12 rsensitivity, and monitored ex vivo reporter bioluminescence.

13 Tumor burden was tracked weekly via bioluminescence.

14 uorin regeneration, leading to a decrease in bioluminescence.

15 and the D-luciferin substrate had levels of bioluminescence 11-fold greater than colons of mice give

16 demonstrates that cell-type-specific in vivo bioluminescence accurately detects changes in multiple i

17 able to functionally converge, resulting in bioluminescence across animal phyla, and describes and c

18 ma cells with aequorin reporter gene and the bioluminescence activities of stable biosensor were meas

19 em by oxidizers conventionally used to track bioluminescence activity.

20 One explanation for this paradox is that bioluminescence acts as a defence that reduces losses to

21 ppression of tumor size, but the decrease of bioluminescence after CR-PIT was not observed consistent

22 in Eastern United States, produce the bluest bioluminescence among insects from translucent areas ass

23 plying a mechanochemical procedure to induce bioluminescence analogous to that used by the marine ost

24 Loss of bioluminescence and a 4-log reduction in viable cells wa

25 luciferases promises to expand the power of bioluminescence and allow multiple events to be imaged i

26 re oxygen [8] and energy (NADH or NADPH) for bioluminescence and are reported to emit green light (la

27 V promoter and NFkappaB binding sequence for bioluminescence and biosensor evaluation.

28 tastatic spreading by three-dimensional (3D) bioluminescence and cross-validated it with standard bio

29 BKC showed no significant difference between bioluminescence and enumeration.

30 acy tests (PET) using bacterial replication, bioluminescence and fluorescence in a three-way study.

31 Using a combination of ex vivo bioluminescence and in vivo gene expression, we report f

32 the LAMP amplification including turbidity, bioluminescence and intercalating fluorescent dyes.

33 However, Malcosteus niger produces far-red bioluminescence and its longwave retinal sensitivity is

34 Our study demonstrates that dual noninvasive bioluminescence and NIR fluorescence imaging of cancer x

35 S/AinR pheromone-signaling system to control bioluminescence and other symbiotic colonization factors

36 Bioluminescence and PET imaging of B7H3-sr39tk CAR T cel

37 The ADSCs were tracked using bioluminescence and photoacoustic imaging serially over

38 to further analyze the properties of fungal bioluminescence and propose novel synthetic analogues.

39 ctivity of exposed airway samples using both bioluminescence and standard colony-forming unit assays.

40 odel, studying the tumor growth over time by bioluminescence and the anti-angiogenic effects.

41 tribute to understanding a de novo origin of bioluminescence and the corresponding gene cluster in a

42 al (metastatic) growth were quantified using bioluminescence and were then used to generate a mathema

43 Cells were tracked by bioluminescence, and 4 weeks post-injection, the newly f

44 ements of tumor volume, 4T1-luc breast tumor bioluminescence, and survival.

45 y also help in developing new hispidin-based bioluminescence applications.

46 uch as those of radioluminescence (1-1.5 h), bioluminescence ( approximately 30 min) and low-excitati

47 hat energy-consuming processes (motility and bioluminescence) are downregulated, and microarray-based

48 cycles suggests a mechanical stimulation of bioluminescence, as organisms carried by currents collid

49 ay formats have been developed, namely (a) a bioluminescence assay exploiting a luciferase mutant wit

50 pared to the adenosine 5'-triphosphate (ATP) bioluminescence assay in microtiter plates.

51 rcadian rhythms in C elegans recorded with a bioluminescence assay in vivo and demonstrate the main f

52 eport the development of a stable cell-based bioluminescence assay of the transcription factor activi

53 A bioluminescence assay was employed to study their inhibi

54 el-free MS proteomics, and promoter reporter bioluminescence assays, we discovered here that viperin

55 Bioluminescence based on Saa3 promoter activity in Saa3-

56 e and have a better signal-to-noise ratio, a bioluminescence-based assay was developed against IFN-ga

57 ominent reporter protein for a wide range of bioluminescence-based detection applications.

58 We demonstrate robust bioluminescence-based detection of hypnozoites in 96-wel

59 iew article, we summarize recent advances in bioluminescence-based imaging approaches that promise to

60 Bioluminescence-based imaging of living cells has become

61 The bioluminescence-based KinCon biosensor allows the tracki

62 eveloped a highly sensitive and quantitative bioluminescence-based readout method.

63 Here, using a highly effective bioluminescence-based reporter system and other tools, w

64 Bioluminescence-based screening of small molecule modula

65 Bioluminescence (BL) is a spectacular phenomenon involvi

66 served as a marker of infection detected as bioluminescence (BLM) by in vivo and ex vivo imaging.

67 urine cerebellar granule neurons, along with bioluminescence, calcium FLIPR, and short hairpin RNA-ba

68 occurs across diverse taxa, measurements of bioluminescence can be powerful to detect and quantify o

69 The luciferase-catalyzed bioluminescence can be quenched by peptide-conjugating A

70 50,000 observations are classified for their bioluminescence capability based on literature descripti

71 ed that 76% of the observed individuals have bioluminescence capability.

72 acterial infection imaging for fluorescence, bioluminescence, chemiluminescence and photoacoustic ima

73 sing standard microscopy techniques, such as bioluminescence, chemiluminescence or radioluminescence.

74 Good correlations between bioluminescence, colony-forming units (CFU) count and fl

75 Bioluminescence commonly influences pelagic trophic inte

76 ent pelagic photon budget, which we term the bioluminescence compensation depth.

77 ared to placebo (p = 0.04, n = 21) without a bioluminescence correlate (t = 0.67, p = 0.52).

78 nd cut off, which results in the recovery of bioluminescence due to the release of luciferase from Au

79 for precise timing and expression levels of bioluminescence during quorum sensing.

80 ence detection (including chemiluminescence, bioluminescence, electrogenerated chemiluminescence, and

81 We show that bioluminescence evolved in the last common ancestor of m

82 Coincident at this depth was bioluminescence exceeding atmospheric light in the ambie

83 species or higher rates in lineages that use bioluminescence for defense, a function presumably not u

84 ed by: Near infrared fluorescent biomarkers, bioluminescence (for tumor proliferation status), Photoa

85 The transducer also controls bioluminescence from firefly luciferase by affecting sol

86 gle i.p. injections of g-E and g-EAR delayed bioluminescence from metastasizing ES-2-luc cells for 2

87 Finally, bioluminescence functions in communication, attracting p

88 ent plants engineered to express a bacterial bioluminescence gene cluster in plastids have not been w

89 We first identified H-NS as a repressor of bioluminescence gene expression, for which LuxR is a req

90 r (IHF) is a key coactivator of the luxCDABE bioluminescence genes that is required together with Lux

91 ecessary for transcription activation of the bioluminescence genes, suggesting that the primary role

92 se to activate transcription of the luxCDABE bioluminescence genes.

93 Bioluminescence has been widely used for important biose

94 cent proteins from bioluminescent organisms, bioluminescence has been widely used for various biologi

95 Given these results, bioluminescence has to be considered an important ecolog

96 Discrete medullar lesions, confirmed by bioluminescence images, were efficiently imaged with [(8

97 uency ultrasound (HF-US) and/or twice weekly bioluminescence imaging (BLI) and confirmed with end-poi

98 njected, and tumor growth was monitored with bioluminescence imaging (BLI) and magnetic resonance ima

99 wo iRFP chimeras enables combined multicolor bioluminescence imaging (BLI) and the respective multico

100 Bioluminescence imaging (BLI) is commonly used for such

101 e different luciferin substrates, means that bioluminescence imaging (BLI) is set to revolutionize lo

102 Bioluminescence imaging (BLI) is ubiquitous in scientifi

103 d area of murine heart and probed by MRI and bioluminescence imaging (BLI).

104 arginase-1 so that they could be detected by bioluminescence imaging and luciferase measured in the b

105 tumor viability and volume were monitored by bioluminescence imaging and ultrasound imaging.

106 However, many bioluminescence imaging applications are limited by the

107 Bioluminescence imaging became a widely used technique f

108 In vivo bioluminescence imaging has been used to monitor Staphyl

109 ular shutdown was demonstrated using dynamic bioluminescence imaging in a human prostate tumor xenogr

110 Bioluminescence imaging is a powerful approach for visua

111 xytamoxifen, by employing FLuc-based optical bioluminescence imaging of living mice.

112 ocyclic drug efficacy using highly sensitive bioluminescence imaging of murine infections.

113 address this knowledge gap through real-time bioluminescence imaging of transgenic Nrf2-luciferase (N

114 Liver tissues were collected and analyzed by bioluminescence imaging or immunofluorescence.

115 their ability to target brain cells, in vivo bioluminescence imaging revealed that targeted-exosome c

116 In vivo bioluminescence imaging showed ECFC persisted for 14 day

117 Bioluminescence imaging showed stable engraftment with n

118 e model system in combination with real-time bioluminescence imaging to demonstrate the relative impo

119 efficiency, we used nonlinear ultrasound and bioluminescence imaging to optimize the acoustic pressur

120 used to track tumor-infiltrating bacteria by bioluminescence imaging upon application to mice, thereb

121 vasive visualization of tumor vascularity by bioluminescence imaging was possible.

122 Bioluminescence imaging was used to monitor tumor growth

123 SPECT imaging and bioluminescence imaging were performed daily up to 48 h

124 cific expression of luciferase and performed bioluminescence imaging with an FFA probe.

125 oped to monitor biofilm formation, utilizing bioluminescence imaging with equine P. aeruginosa isolat

126 Bioluminescence imaging with luciferase-luciferin pairs

127 Bioluminescence imaging with luciferase-luciferin pairs

128 Optical density, bioluminescence imaging, and Colony Forming Unit assessm

129 ed carrying reporter genes for fluorescence, bioluminescence imaging, and human PET reporter genes.

130 escence and cross-validated it with standard bioluminescence imaging, caliper measurement and necrops

131 Bioluminescence imaging, histological examination, and c

132 pathways in diseased organs using whole-body bioluminescence imaging, in conscious, freely moving rod

133 Tumor growth was monitored with bioluminescence imaging, showing that CAR T cell treatme

134 ompromised mice, and followed by noninvasive bioluminescence imaging.

135 nd tumors were imaged over time with PET and bioluminescence imaging.

136 effects of CR-PIT in vitro and in vivo using bioluminescence imaging.

137 s produced, which can be detected by in vivo bioluminescence imaging.

138 ing the engraftment ratio (ER) using in vivo bioluminescence imaging.

139 Metastasis was monitored by bioluminescence imaging.

140 inant Gaussia luciferase (rGluc) protein and bioluminescence imaging.

141 rugs on p53 sumoylation in living mice using bioluminescence imaging.

142 Tumor growth was monitored using bioluminescence imaging.

143 vated downstream ER signaling as measured by bioluminescence imaging.

144 gical events in vivo has long been a goal in bioluminescence imaging.

145 d voltage-regulated H(+) channels activating bioluminescence in firefly and jellyfish.

146 Here, we show that copepodamide-induced bioluminescence in L. polyedra causes a marked shift in

147 lso suggests that the evolutionary origin of bioluminescence in nonphotosynthetic dinoflagellates may

148 eflected by a significant increase in ocular bioluminescence in one myeloid reporter line on day 2.

149 polyedra (F.Stein) J.D.Dodge increase their bioluminescence in response to copepodamides [5], polar

150 vo functionality for measuring time-resolved bioluminescence in rodent brains.

151 rs may help improve the detection of pelagic bioluminescence in shallow water at night.

152 eds through a mechanism identical to that of bioluminescence in solution, but has higher activation e

153 to cover the major existing applications for bioluminescence in the context of the diversity of lucif

154 We detected localised bioluminescence in the liver (APAP) and kidneys (cisplat

155 leading to a significant increase in ocular bioluminescence in the T cell reporter line.

156 garicales represent an independent origin of bioluminescence in the tree of life; yet the diversity,

157 on of the invertebrate Daphnia magna and the bioluminescence inhibition of the marine bacteria Vibrio

158 The bioluminescence intensity at 470 nm is observed, and inc

159 The bioluminescence intensity of aequorin was proportional t

160 The bioluminescence intensity of this designed sensor is sig

161 Fungal bioluminescence is a fascinating natural process, standi

162 Bioluminescence is a powerful biological signal that sci

163 Bioluminescence is a prominent functional trait used for

164 ation of bioluminescent data is limited: the bioluminescence is different from gene expression becaus

165 additional independent origin of endogenous bioluminescence is found within ostracods from the famil

166 capability of animals to emit light, called bioluminescence, is considered to be a major factor in e

167 ence suggesting pressure to reduce reflected bioluminescence led to the evolution of ultra-black skin

168 ich converts the antibody-antigen binding to bioluminescence light.

169 This is in agreement with bioluminescence live imaging, confocal microscopy, and h

170 rol of several cellular processes, including bioluminescence (luciferase), fluorescence (enhanced gre

171 oped a highly translational and quantitative bioluminescence microscopy method to measure single cell

172 firefly luciferase, thus enabling autonomous bioluminescence microscopy of mammalian cells.

173 uciferase reporter transgene for noninvasive bioluminescence monitoring of CREB activity.

174 Bioluminescence monitoring revealed efficient and rapid

175 substrates to catalyze reactions involved in bioluminescence, nonribosomal peptide biosynthesis, fatt

176 Bioluminescence of a variety of marine organisms, mostly

177 active predator, E. scolopes coordinates the bioluminescence of its symbiont with visual cues from th

178 cted by a significant increase in the ocular bioluminescence of the B cell reporter line starting on

179 0.65 mm(3) +/- 0.15, P < .0001) and relative bioluminescence optical imaging photon signal (0.57 x 10

180 0.65 mm(3) +/- 0.15, P < .0001) and relative bioluminescence optical imaging photon signal (0.57 x 10

181 Bioluminescence, or the production of light by living or

182 oring of viral inhibition by fluorescence or bioluminescence, overcoming the limitations associated w

183 lation coefficients between CFU and relative bioluminescence; P. aeruginosa ATCC9027 tatH5-pMElux is

184 In this work we reconstitute a fungal bioluminescence pathway (FBP) in planta using a composab

185 lia site, were used to characterize rhythmic bioluminescence patterns in June 2013, in response to wa

186 tinuously, implying a metabolic function for bioluminescence, perhaps as a byproduct of oxidative met

187 Importantly, whole-body bioluminescence persisted up to 240 days.

188 Bioluminescence potential of the community increased wit

189 This mechanically assisted bioluminescence proceeds through a mechanism identical t

190 ted-state formation in chemiluminescence and bioluminescence processes.

191 sion for numerous group behaviors, including bioluminescence production, biofilm formation, virulence

192 ng flow cytometry and compared to the ocular bioluminescence profile.

193 that for subcutaneously implanted cells, NIR bioluminescence provided a 10-fold increase in sensitivi

194 ty compared with fluorescent beacon systems, bioluminescence quenching is still comparatively ineffic

195 a dioxetanone anion, thereby triggering the bioluminescence reaction in the ctenophore photoprotein

196 red with the broadband time-resolved firefly bioluminescence recorded in vivo.

197 Ex-vivo bioluminescence recordings of ileum mucosae from transge

198 In long-term bioluminescence recordings, GABAA receptor blockade desy

199 ATP-driven bioluminescence relying on the D-luciferin-luciferase re

200 Because direct observation of in situ bioluminescence remains a technical challenge, taxa from

201 Using a bioluminescence reporter approach, we sought to determin

202 llular cytotoxicity (ADCC) was measured by a bioluminescence reporter assay.

203 maximal information coefficient statistic to bioluminescence reporter data from individual neurons wh

204 Red-shifted bioluminescence reporters are desirable for biological i

205 o and in vivo sensitivity over commonly used bioluminescence reporters.

206 But bioluminescence requires the interaction of a luciferase

207 Here, we describe a targeted bioluminescence resonance energy transfer (BRET) assay,

208 We developed bioluminescence resonance energy transfer (BRET) assays

209 Multiplexed bioluminescence resonance energy transfer (BRET) assays

210 ouple to dopamine D1R receptors by real-time bioluminescence resonance energy transfer (BRET) assays.

211 Due to an intramolecular bioluminescence resonance energy transfer (BRET) between

212 Bioluminescence resonance energy transfer (BRET) has bee

213 Our lab has developed a bioluminescence resonance energy transfer (BRET) imaging

214 Using bioluminescence resonance energy transfer (BRET) in live

215 In bioluminescence resonance energy transfer (BRET) interac

216 Bioluminescence resonance energy transfer (BRET) is a se

217 ecular fluorescein arsenical hairpin (FlAsH) bioluminescence resonance energy transfer (BRET) reporte

218 Using a Galphao-betagamma bioluminescence resonance energy transfer (BRET) sensor,

219 salmeterol-mediated desensitization through bioluminescence resonance energy transfer (BRET) studies

220 Using bioluminescence resonance energy transfer (BRET) technol

221 Raf proteins to interact in live cells using bioluminescence resonance energy transfer (BRET) technol

222 Bioluminescence resonance energy transfer (BRET) technol

223 sent a new sensor platform (LUMABS) based on bioluminescence resonance energy transfer (BRET) that al

224 The assay uses bioluminescence resonance energy transfer (BRET) to dete

225 We utilized bioluminescence resonance energy transfer (BRET) to dete

226 Here we use bioluminescence resonance energy transfer (BRET) to show

227 We have used bioluminescence resonance energy transfer (BRET) to stud

228 Using bioluminescence resonance energy transfer (BRET), HO-1 f

229 robing the receptor for ubiquitination using bioluminescence resonance energy transfer (BRET), we det

230 Using bioluminescence resonance energy transfer (BRET)-based a

231 operties and high affinity, as determined by bioluminescence resonance energy transfer (BRET)-based s

232 (++) sensor that is ratiometric by virtue of bioluminescence resonance energy transfer (BRET).

233 es of unlabeled hA(2A)AR antagonists using a bioluminescence resonance energy transfer (NanoBRET) ass

234 Here we establish a nanoluciferase bioluminescence resonance energy transfer (NanoBRET)-bas

235 lphas, and beta-arrestin1 were studied using bioluminescence resonance energy transfer 2 (BRET(2)) in

236 e now use competitive inhibition of receptor bioluminescence resonance energy transfer and bimolecula

237 Using intermolecular bioluminescence resonance energy transfer and proximity

238 Using cross-linking and bioluminescence resonance energy transfer approaches, we

239 Bioluminescence resonance energy transfer assays for Gi

240 Fast kinetic bioluminescence resonance energy transfer assays in tran

241 T was detected by co-immunoprecipitation and bioluminescence resonance energy transfer assays.

242 -fused Galpha constructs that can be used in bioluminescence resonance energy transfer assays.

243 vator, to the Golgi apparatus, determined by bioluminescence resonance energy transfer between Ggamma

244 of ligand-mediated receptor activation using bioluminescence resonance energy transfer biosensors rev

245 Bioluminescence resonance energy transfer experiments pr

246 Bioluminescence resonance energy transfer measurements i

247 APJ mutants in TMD1 and TMD2 also decreased bioluminescence resonance energy transfer of APJ dimer.

248 Co-immunoprecipitation and bioluminescence resonance energy transfer studies confir

249 n of the split HuR luciferase assay with the bioluminescence resonance energy transfer technique sugg

250 Using a split luciferase assay, a bioluminescence resonance energy transfer technique, and

251 Bioluminescence resonance energy transfer was employed t

252 emical and biophysical approaches, including bioluminescence resonance energy transfer, and mammalian

253 We used in vitro bioluminescence resonance energy transfer, ex vivo analy

254 Using bioluminescence resonance energy transfer, immunofluores

255 Using bioluminescence resonance energy transfer-based and cell

256 ocal microscopy or with a recently developed bioluminescence resonance energy transfer-based approach

257 ith measuring changes in the GAP activity by bioluminescence resonance energy transfer-based assay in

258 EPR spectroscopy-based studies coupled with bioluminescence resonance energy transfer-based cellular

259 eceptor signaling to NF-kappaB, we developed bioluminescence resonance energy transfer-based interact

260 genome-edited to not express G proteins and bioluminescence resonance energy transfer-based sensors,

261 1)R-G279S(7.44) by coimmunoprecipitation and bioluminescence resonance energy transfer.

262 to form a functional carrier as assessed by bioluminescence resonance energy transfer; 3) in MPC1 de

263 We adapted this pair to develop a bioluminescence resonance-energy-based Antares reporter

264 mine induced phase-advances of the PER2::LUC bioluminescence rhythm during the subjective day and pha

265 responsible for entrainment of the PER2::LUC bioluminescence rhythm in mouse RPE-choroid.

266 circadian and rapidly induced PER2-dependent bioluminescence rhythms in previously arrhythmic Cry1/2-

267 ior under light/dark cycles and free-running bioluminescence rhythms with periods of ~21-31 h that da

268 Moreover, the SiPM-based bioluminescence sensing system shows a similar analytica

269 A miniaturised bioluminescence sensing system, which would allow sensit

270 esulting in a significant disconnect between bioluminescence signal and cell number.

271 ltrasonographic imaging were used to observe bioluminescence signal and changes in tumor size among t

272 at the luciferase expressing cell number and bioluminescence signal are linearly proportional.

273 lly provided luciferin substrate and the low bioluminescence signal which restricts the sensitivity a

274 ificant (p < 0.05) 20.5 h periodicity in the bioluminescence signal, corresponding to inertial fluctu

275 vein inoculation, most luciferase-generated bioluminescence signals were detected in the mouse abdom

276 abolism, only living bacteria are capable of bioluminescence, so the signal is lost upon ingestion.

277 cence with an emission spectrum matching the bioluminescence spectrum (~460 nm), indicating that it i

278 ange of the residual daylight as well as the bioluminescence spectrum present in the deep sea.

279 owledge gained from the literature to assess bioluminescence status.

280 e results could suggest a photoprotein-based bioluminescence system as a highly sensitive, specific,

281 The bacterial bioluminescence system is fully genetically encodable an

282 We engineered tobacco plants with a fungal bioluminescence system that converts caffeic acid (prese

283 TMZ)/PT2385 (p = 0.44, n = 10) or mean tumor bioluminescence (t 1.13, p = 0.32).

284 g, wave guiding and lensing, camouflage, and bioluminescence, that are responsible for the unique opt

285 eports the use of cell-type-specific in vivo bioluminescence to measure intraocular immune cell popul

286 erases and luciferins, further expanding the bioluminescence toolkit.

287 layers (eDIBs), or artificial cells, and the bioluminescence tracked in real time for accurate quanti

288 lized and quantified in vitro and in vivo as bioluminescence using an imaging system.

289 We quantified the loss of bioluminescence using N2 reference worms and eat-2 mutan

290 xins biosynthesis, siderophore biosynthesis, bioluminescence, vitamin K metabolism, brominated compou

291 ells, and B cells) were generated and ocular bioluminescence was measured serially for 35 days follow

292 Fungal bioluminescence was recently shown to depend on a unique

293 anslocator-like:luciferase ( BMAL:LUC)], and bioluminescence was recorded over a period of 3 d.

294 Tumor burden, as determined by bioluminescence, was decreased in (+)-JQ1 treated mice c

295 gical iron and catalytic energy for the worm bioluminescence when coupled to a reduction process with

296 nism is based on the measurement of aequorin bioluminescence, where the lower the concentration of co

297 iRFPs, the chimeric luciferases exhibit NIR bioluminescence with maxima at 670 nm and 720 nm, respec

298 ally encodable and hence produces autonomous bioluminescence without an external luciferin, but its b

299 off of the promoter, or where an increase in bioluminescence would be better interpreted as a longer

300 We show examples where a decrease in bioluminescence would be better interpreted as a switchi